NEW YORK — AccurKardia, an ECG analytics software company focused on establishing ECG as a broad biomarker, today announced a multi-year agreement with Specialized Medical. Under this partnership, AccurKardia’s FDA-cleared Class II software as a medical device (SaMD), AccurECG™ 2.0, is actively powering Specialized Medical’s state-of-the-art cardiac monitoring operations, which currently serve more than 20 clinics, medical practices, and hospitals across four states.
Specialized Medical delivers live-streaming, real-time ECG data through the S-Patch Monitoring System, giving physician practices four tests from one device (Holter, Extended Holter, Event, and Mobile Cardiac Telemetry), 24/7 live monitoring, real-time alerts, EMR-ready reporting, and a simpler end-to-end workflow from start to finish. Built for modern cardiac monitoring, the solution is designed for resilient connectivity across a wide range of patient environments, including rural areas, helping reduce data gaps, improve confidence in every test, and support faster clinical decisions.
By combining Specialized Medical’s resilient hardware connectivity and robust operations capabilities with AccurKardia’s best-in-class ECG analytics, the integrated operations are setting a new standard for how cardiac data is analyzed and delivered at scale.